Literature DB >> 22234307

Human hepatitis B viral e antigen and its precursor P20 inhibit T lymphocyte proliferation.

Maija Purvina1, Astrid Hoste, Jean-Michel Rossignol, Cécile Lagaudrière-Gesbert.   

Abstract

The hepatitis B virus (HBV) Precore protein is processed through the secretory pathway directly as HBeAg or with the generation of an intermediate (P20). Precore gene has been shown to be implicated in viral persistence, but the functions of HBeAg and its precursors have not been fully elucidated. We show that the secreted proteins HBeAg and P20 interact with T cell surface and alter Kit-225 and primary T cells proliferation, a process which may facilitate the establishment of HBV persistence. Our data indicate that the N-terminal end of Precore is important for these inhibitory effects and exclude that they are dependent on the association of HBeAg and P20 with two characterized cell surface ligands, the Interleukin-1 Receptor Accessory Protein and gC1qR (present study).
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22234307     DOI: 10.1016/j.bbrc.2011.12.138

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  The improvement effects of edible bird's nest on proliferation and activation of B lymphocyte and its antagonistic effects on immunosuppression induced by cyclophosphamide.

Authors:  Ran Zhao; Geng Li; Xiu-Juan Kong; Xiu-Yan Huang; Wei Li; Yao-Ying Zeng; Xiao-Ping Lai
Journal:  Drug Des Devel Ther       Date:  2016-01-21       Impact factor: 4.162

Review 2.  Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection.

Authors:  Ana Maria Ortega-Prieto; Marcus Dorner
Journal:  Vaccines (Basel)       Date:  2017-09-01

3.  Antigenic switching of hepatitis B virus by alternative dimerization of the capsid protein.

Authors:  Michael A DiMattia; Norman R Watts; Stephen J Stahl; Jonathan M Grimes; Alasdair C Steven; David I Stuart; Paul T Wingfield
Journal:  Structure       Date:  2012-12-06       Impact factor: 5.006

4.  HBsAg as an important predictor of HBeAg seroconversion following antiviral treatment for HBeAg-positive chronic hepatitis B patients.

Authors:  Jiezuan Yang; Jiajia Chen; Ping Ye; Linfeng Jin; Wei Wu; Guoping Sheng; Lan-Juan Li
Journal:  J Transl Med       Date:  2014-06-25       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.